The present study paves the way for further research into the potential clinical applications of Cu(ATSM) and similar compounds that target P-gp expression and function at the BBB and offers hope for the development of more effective drug therapies for neurodegenerative diseases such as AD. Here, PGP is linked to Alzheimer disease.